Lee JD - Search Results

1

Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.

Cantin GT, Yi W, Lu B, Park SK, Xu T, Lee JD, Yates JR 3rd. Cantin GT, et al. Among authors: lee jd. J Proteome Res. 2008 Mar;7(3):1346-51. doi: 10.1021/pr0705441. Epub 2008 Jan 26. J Proteome Res. 2008. PMID: 18220336

2

Combined integrin phosphoproteomic analyses and small interfering RNA--based functional screening identify key regulators for cancer cell adhesion and migration.

Chen Y, Lu B, Yang Q, Fearns C, Yates JR 3rd, Lee JD. Chen Y, et al. Among authors: lee jd. Cancer Res. 2009 Apr 15;69(8):3713-20. doi: 10.1158/0008-5472.CAN-08-2515. Epub 2009 Apr 7. Cancer Res. 2009. PMID: 19351860 Free PMC article.

3

CDC25B mediates rapamycin-induced oncogenic responses in cancer cells.

Chen RQ, Yang QK, Lu BW, Yi W, Cantin G, Chen YL, Fearns C, Yates JR 3rd, Lee JD. Chen RQ, et al. Among authors: lee jd. Cancer Res. 2009 Mar 15;69(6):2663-8. doi: 10.1158/0008-5472.CAN-08-3222. Epub 2009 Mar 10. Cancer Res. 2009. PMID: 19276368 Free PMC article.

4

Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein.

Yang Q, Deng X, Lu B, Cameron M, Fearns C, Patricelli MP, Yates JR 3rd, Gray NS, Lee JD. Yang Q, et al. Among authors: lee jd. Cancer Cell. 2010 Sep 14;18(3):258-67. doi: 10.1016/j.ccr.2010.08.008. Cancer Cell. 2010. PMID: 20832753 Free PMC article.

5

Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma.

Song C, Wang L, Xu Q, Wang K, Xie D, Yu Z, Jiang K, Liao L, Yates JR, Lee JD, Yang Q. Song C, et al. Among authors: lee jd. Sci Rep. 2017 Apr 7;7:46244. doi: 10.1038/srep46244. Sci Rep. 2017. PMID: 28387310 Free PMC article.

6

PML Recruits TET2 to Regulate DNA Modification and Cell Proliferation in Response to Chemotherapeutic Agent.

Song C, Wang L, Wu X, Wang K, Xie D, Xiao Q, Li S, Jiang K, Liao L, Yates JR 3rd, Lee JD, Yang Q. Song C, et al. Among authors: lee jd. Cancer Res. 2018 May 15;78(10):2475-2489. doi: 10.1158/0008-5472.CAN-17-3091. Epub 2018 May 7. Cancer Res. 2018. PMID: 29735542 Free PMC article.

7

Corrigendum: Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma.

Song C, Wang L, Xu Q, Wang K, Xie D, Yu Z, Jiang K, Liao L, Yates JR, Lee JD, Yang Q. Song C, et al. Among authors: lee jd. Sci Rep. 2017 May 26;7:46833. doi: 10.1038/srep46833. Sci Rep. 2017. PMID: 28548101 Free PMC article.

8

Big mitogen-activated protein kinase 1/extracellular signal-regulated kinase 5 signaling pathway is essential for tumor-associated angiogenesis.

Hayashi M, Fearns C, Eliceiri B, Yang Y, Lee JD. Hayashi M, et al. Among authors: lee jd. Cancer Res. 2005 Sep 1;65(17):7699-706. doi: 10.1158/0008-5472.CAN-04-4540. Cancer Res. 2005. PMID: 16140937

9

Tid1, the human homologue of a Drosophila tumor suppressor, reduces the malignant activity of ErbB-2 in carcinoma cells.

Kim SW, Chao TH, Xiang R, Lo JF, Campbell MJ, Fearns C, Lee JD. Kim SW, et al. Among authors: lee jd. Cancer Res. 2004 Nov 1;64(21):7732-9. doi: 10.1158/0008-5472.CAN-04-1323. Cancer Res. 2004. PMID: 15520177

10

Tid1 negatively regulates the migratory potential of cancer cells by inhibiting the production of interleukin-8.

Kim SW, Hayashi M, Lo JF, Fearns C, Xiang R, Lazennec G, Yang Y, Lee JD. Kim SW, et al. Among authors: lee jd. Cancer Res. 2005 Oct 1;65(19):8784-91. doi: 10.1158/0008-5472.CAN-04-4422. Cancer Res. 2005. PMID: 16204048

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,832 results

Search Page

Filters